Tools
Stock profile

Element Solutions Inc (ESI)

ESI · Latest close $32.57 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$32.57
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

Element Solutions Inc (ESI) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 1 fund trimming or exiting versus the previous quarter. Latest close $32.57 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

First Eagle Investment Management · Maverick Capital — 2 tracked funds hold ESI. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

Orion S.A. (OEC) · FLOTEK INDUSTRIES INC/CN/ (FTK) · ASP Isotopes Inc. (ASPI) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
First Eagle Investment Management0.03%366,600ADDED (+548.8%) Q3 filed Nov 10
Maverick Capital0.01%12,812TRIMMED (-70.6%) Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -30.4% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

49.0916.242024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding501 of 8,857 filers
Long-only filers among them499
Change vs 2026 Q1+64 net · 476 entered · 412 exited
Shares reported, all filers254,350,458
Reported value, all filers$11.2B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryMiscellaneous Chemical Products (SIC 2890)
Revenue · FY2025$2.6B
Net income · FY2025$190.8M
Total assets · FY2025$5.1B
Shares outstanding242,602,998
Market cap (at latest close)$7.9B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 15, 2026.

Short interest

Shares short · Oct 15, 20268,553,322
Share of shares outstanding3.53%
Days to cover2.41

Shares short at recent settlements — Jul 31, 2026: 9.1M · Aug 14, 2026: 6.5M · Aug 31, 2026: 7.1M · Sep 15, 2026: 6.9M · Sep 30, 2026: 7.6M · Oct 15, 2026: 8.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 15, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 12K · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 15, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Feb 24, 2026Benjamin GliklichOfficer, Director180,000$6.5MFeb 24, 2026SEC filing
Feb 23, 2026Carey J. DormanOfficer97,500$3.5MFeb 23, 2026SEC filing
Feb 20, 2026ONEAL E STANLEYDirector200,641$7.1MFeb 20, 2026SEC filing
Feb 11, 2026Liebowitz MatthewOfficer14,845$474.6KFeb 11, 2026SEC filing
Feb 11, 2026Gliklich BenjaminOfficer, Director82,886$2.6MFeb 11, 2026SEC filing
Feb 11, 2026Fricke Richard L.Officer10,023$320.7KFeb 11, 2026SEC filing
Feb 11, 2026Dorman Carey J.Officer33,452$1.1MFeb 11, 2026SEC filing
Feb 11, 2026Capps John EdwardOfficer13,680$437.3KFeb 11, 2026SEC filing
Dec 12, 2025Liebowitz MatthewOfficer37,000$984.3KDec 12, 2025SEC filing
Nov 5, 2025Ian G. H. AshkenDirector292,000$7.9MNov 5, 2025SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Mar 23, 2026SCHEDULE 13D/A-5.8% (close Mar 24, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Mar 24, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 13, 2026Invesco Ltd.SC 13G12,633,1305.2%Jun 30, 2026SEC filing
Apr 29, 2026Vanguard Portfolio ManagementSC 13G13,690,3225.6%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Capital ManagementSC 13G12,480,5065.1%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Mar 23, 2026Martin E. FranklinSC 13D/A11,282,9834.6%Mar 23, 2026SEC filing
Apr 7, 2025The Vanguard GroupSC 13G/A24,932,85110.3%Mar 31, 2025SEC filing
Apr 3, 2025BlackRock, Inc.SC 13G25,962,97910.7%Mar 31, 2025SEC filing
Feb 12, 2025FMR LLCSC 13G/A18,442,642.937.6%Dec 31, 2024SEC filing
Jan 23, 2025Dimensional Fund Advisors LPSC 13G/A9,877,7624.1%Dec 31, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Miscellaneous Chemical Products (SIC 2890). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Financial Screens

· Graham — Sound finances and a long run of profits

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

Key figures

· Graham — Current ratio: 3.68 · Straight profitable years: 7 · Debt ratio: 0.90 · Latest net income: $190.8M

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 2.28 · Operating cash flow: $295.9M · Net income: $187.2M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Also held by the tracked funds that hold ESI — ranked by lift, the co-holding pattern described in Methodology: Orion S.A. (OEC) · FLOTEK INDUSTRIES INC/CN/ (FTK) · ASP Isotopes Inc. (ASPI) · CABOT CORP (CBT) · Merck & Co., Inc. (MRK) · LINDE PLC (LIN) · ELI LILLY & Co (LLY) · PROCTER & GAMBLE Co (PG).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Oct 21, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 28, 20261.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Jul 27, 20262.02 Results of Operations and Financial ConditionSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Orion S.A. (OEC) · Track Record: how the signals scored · Practice timing on ESI

One email a week: the week’s new filings and research. Subscribe free

← ESE  ·  ESLT →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.